CY1108572T1 - Φαρμακα για nοσους του αμφιβληστροειδους και του χορειοειδους χιτωνα που περιεχουν στερεοειδη ως δραστικο συστατικο - Google Patents
Φαρμακα για nοσους του αμφιβληστροειδους και του χορειοειδους χιτωνα που περιεχουν στερεοειδη ως δραστικο συστατικοInfo
- Publication number
- CY1108572T1 CY1108572T1 CY20081101320T CY081101320T CY1108572T1 CY 1108572 T1 CY1108572 T1 CY 1108572T1 CY 20081101320 T CY20081101320 T CY 20081101320T CY 081101320 T CY081101320 T CY 081101320T CY 1108572 T1 CY1108572 T1 CY 1108572T1
- Authority
- CY
- Cyprus
- Prior art keywords
- active ingredient
- steeroid
- medicines
- diseases
- extracts containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Ένας στόχος της παρούσας εφεύρεσης είναι να παράσχει θεραπευτικούς παράγοντες για διαταραχές του αμφιβληστροειδούς και του χοριοειδούς που περιλαμβάνουν ένα στεροειδές ως ένα δραστικό συστατικό και που έχουν βελτιωμένες επιδράσεις και δοσολογικές μορφές για θεραπεία των διαταραχών του αμφιβληστροειδούς και του χοριοειδούς όπου το στεροειδές μπορεί να χορηγείται εύκολα. Η παρούσα εφεύρεση αφορά σε θεραπευτικούς παράγοντες για διαταραχές του αμφιβληστροειδούς και του χοριοειδούς που περιλαμβάνουν βηταμεθαζόνη ή υδροκορτιζόνη ως ένα δραστικό συστατικό και σε εγχύσεις κάτω από τον επιπεφυκότα που περιλαμβάνουν το στεροειδές ως ένα δραστικό συστατικό.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001092329 | 2001-03-28 | ||
EP02708676A EP1380302B1 (en) | 2001-03-28 | 2002-03-27 | Remedies for retina and choroid diseases containing steroids as the active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108572T1 true CY1108572T1 (el) | 2014-04-09 |
Family
ID=18946808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101320T CY1108572T1 (el) | 2001-03-28 | 2008-11-17 | Φαρμακα για nοσους του αμφιβληστροειδους και του χορειοειδους χιτωνα που περιεχουν στερεοειδη ως δραστικο συστατικο |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040097478A1 (el) |
EP (1) | EP1380302B1 (el) |
KR (1) | KR100854058B1 (el) |
CN (1) | CN100353947C (el) |
AT (1) | ATE405274T1 (el) |
CA (1) | CA2442296C (el) |
CY (1) | CY1108572T1 (el) |
DE (1) | DE60228431D1 (el) |
DK (1) | DK1380302T3 (el) |
ES (1) | ES2311592T3 (el) |
PT (1) | PT1380302E (el) |
WO (1) | WO2002078713A1 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI347847B (en) * | 2003-08-20 | 2011-09-01 | Santen Pharmaceutical Co Ltd | Drug delivery system for sub-tenon administration of fine particles |
US7374219B2 (en) * | 2004-09-22 | 2008-05-20 | Zephyros, Inc. | Structural reinforcement member and method of use therefor |
RU2696045C1 (ru) * | 2018-10-15 | 2019-07-30 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ лечения болезни Илза |
IT201900014052A1 (it) * | 2019-08-05 | 2021-02-05 | Lucia Scorolli | Preparazione para-bulbare con effetto citotrofico-retinico |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454151A (en) * | 1982-03-22 | 1984-06-12 | Syntex (U.S.A.) Inc. | Use of pyrrolo pyrroles in treatment of ophthalmic diseases |
JPS61106521A (ja) * | 1984-10-31 | 1986-05-24 | Kureha Chem Ind Co Ltd | 血管増殖抑制剤 |
AU637824B2 (en) * | 1989-08-28 | 1993-06-10 | Alcon Laboratories, Inc. | Ophthalmic composition |
US5104787A (en) * | 1990-03-05 | 1992-04-14 | Lindstrom Richard L | Method for apparatus for a defined serumfree medical solution useful for corneal preservation |
KR0185215B1 (ko) * | 1990-11-30 | 1999-05-01 | 요시다 쇼오지 | 서방성 안구삽입용 약제 |
CA2425849C (en) * | 1991-11-22 | 2007-02-27 | Alcon Laboratories, Inc. | Angiostatic steroids |
JPH08503921A (ja) * | 1991-12-20 | 1996-04-30 | アメリカ合衆国 | カポジ肉腫を処置、及び脈管浸透を阻止又は阻害するための方法 |
WO1995003807A1 (en) * | 1993-07-27 | 1995-02-09 | The University Of Sydney | Treatment of age-related macular degeneration |
TW420611B (en) * | 1995-03-10 | 2001-02-01 | R Tech Ueno Ltd | Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder |
JPH11510185A (ja) * | 1995-08-07 | 1999-09-07 | シェーリング コーポレイション | インターロイキン−10を用いた眼の炎症性状態の処置 |
ATE305301T1 (de) * | 1996-11-05 | 2005-10-15 | Childrens Medical Center | Mittel zur hemmung von angiogenese enthaltend thalodomid und einen nsaid |
US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6395294B1 (en) * | 2000-01-13 | 2002-05-28 | Gholam A. Peyman | Method of visualization of the vitreous during vitrectomy |
US6726918B1 (en) * | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
-
2002
- 2002-03-27 EP EP02708676A patent/EP1380302B1/en not_active Expired - Lifetime
- 2002-03-27 WO PCT/JP2002/002950 patent/WO2002078713A1/ja active IP Right Grant
- 2002-03-27 US US10/473,512 patent/US20040097478A1/en not_active Abandoned
- 2002-03-27 CN CNB028074858A patent/CN100353947C/zh not_active Expired - Fee Related
- 2002-03-27 KR KR1020037012670A patent/KR100854058B1/ko not_active IP Right Cessation
- 2002-03-27 DK DK02708676T patent/DK1380302T3/da active
- 2002-03-27 AT AT02708676T patent/ATE405274T1/de active
- 2002-03-27 CA CA2442296A patent/CA2442296C/en not_active Expired - Fee Related
- 2002-03-27 PT PT02708676T patent/PT1380302E/pt unknown
- 2002-03-27 DE DE60228431T patent/DE60228431D1/de not_active Expired - Lifetime
- 2002-03-27 ES ES02708676T patent/ES2311592T3/es not_active Expired - Lifetime
-
2008
- 2008-11-17 CY CY20081101320T patent/CY1108572T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE60228431D1 (de) | 2008-10-02 |
EP1380302B1 (en) | 2008-08-20 |
CA2442296C (en) | 2010-06-22 |
KR100854058B1 (ko) | 2008-08-26 |
ATE405274T1 (de) | 2008-09-15 |
WO2002078713A1 (fr) | 2002-10-10 |
CN100353947C (zh) | 2007-12-12 |
ES2311592T3 (es) | 2009-02-16 |
US20040097478A1 (en) | 2004-05-20 |
PT1380302E (pt) | 2008-11-25 |
EP1380302A4 (en) | 2006-04-12 |
CN1551775A (zh) | 2004-12-01 |
DK1380302T3 (da) | 2008-12-08 |
EP1380302A1 (en) | 2004-01-14 |
CA2442296A1 (en) | 2002-10-10 |
KR20030087029A (ko) | 2003-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8657201A1 (es) | Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos | |
DE60100595D1 (de) | Verbessertes transdermales therapeutisches System zur Behandlung von Morbus Parkinson | |
DE60028740D1 (de) | Phthalazinderivate zur behandlung von entzündlicher erkrankungen | |
HUP0401568A2 (hu) | Periokuláris vagy subconjunctivális adagolásra alkalmas szemészeti depó készítmények | |
TW200505402A (en) | Ophthalmic drug delivery device | |
DE60100994D1 (de) | Transdermales therapeutisches System für die Erzielung hoher Plasmaspiegel von Rotigotin in der Therapie von Morbus Parkinson | |
PA8635901A1 (es) | Nucleosidos de 3-beta-d-ribofuranosiltiazolo [4,5-d] pirimidina y usos de los mismos | |
HUP0203590A2 (hu) | Gyógyszerkészítmény a csonttömeg csökkenésével járó betegségek kezelésére | |
ATE365550T1 (de) | Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie | |
ES2173111T3 (es) | Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos. | |
SE9704644D0 (sv) | New use | |
CY1108572T1 (el) | Φαρμακα για nοσους του αμφιβληστροειδους και του χορειοειδους χιτωνα που περιεχουν στερεοειδη ως δραστικο συστατικο | |
TW200511996A (en) | The use of steroids to treat persons suffering from ocular disorders | |
DK1343472T3 (da) | Thixotropisk næsespray | |
DE60043886D1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
ATE251905T1 (de) | Verwendung von ubiquinon q 10 zur vorbeugung und behandlung von postoperativen okularen pathologien | |
KR102199560B1 (ko) | 니코틴성 아세틸콜린 수용체 작용제로 부비점막 질환을 치료하기 위한 조성물 및 방법 | |
MXPA05014143A (es) | Derivados de cumarina para el tratamiento de trastornos oftalmicos. | |
DE60138385D1 (de) | Heilmittel zur behandlung von erkrankungen des sehnervs | |
Razmi T et al. | Recent advances in pathogenesis and medical management of vitiligo | |
SE9904863D0 (sv) | New use | |
ATE337790T1 (de) | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen | |
BR0212274A (pt) | Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma | |
Priyadarshini et al. | Traversing the “Wickham striae” from pathogenesis, diagnosis to the therapeutic management: a comprehensive review | |
BR112018067718B1 (pt) | Composições para tratamento de doenças da mucosa nasal e paranasal com agonistas do receptor de acetilcolina nicotínica |